NasdaqHealth CareHealth Care ServicesS&P MidCap 400
$67.15
+1.29 (+1.96%)
Close of Nov 06, 2026 · end-of-day data
BTSG 8-K filings, explained
Every material Form 8-K BrightSpring Health Services has filed with the SEC since March 06, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
BrightSpring Health Services reported third quarter 2026 net revenue of $4.21 billion and net income from continuing operations of $101 million, representing significant growth compared to the same period in 2025. Driven by strong performance across its pharmacy and provider businesses, the company also raised its full-year 2026 financial guidance for revenue and Adjusted EBITDA.
Net revenue for the third quarter of 2026 reached $4,213 million, up 26.4% from $3,334 million in the third quarter of 2025.
Adjusted EBITDA for the third quarter of 2026 increased 42.0% to $228 million compared to $160 million in the prior-year period.
Full-year 2026 revenue guidance was increased to a range of $15,900 million to $16,125 million, and Adjusted EBITDA guidance was raised to $850 million to $860 million.
BrightSpring reported second quarter 2026 net revenue of $3.87 billion, up 23.0% from a year earlier, and net income of $87 million compared with $9 million in the second quarter of 2025. The company also raised its full-year 2026 revenue and Adjusted EBITDA guidance, which excludes the Community Living business it divested on March 30, 2026. For shareholders, the quarter shows higher revenue and profit and a higher full-year outlook.
Q2 2026 net revenue of $3,873 million, up 23.0% from $3,148 million; gross profit of $493 million, up 31.5%
Net income of $87 million vs. $9 million in Q2 2025; diluted EPS of $0.38 vs. $0.13 attributable to common shareholders
Full-year 2026 revenue guidance raised to $15,100 million to $15,425 million; Adjusted EBITDA guidance raised to $820 million to $845 million
Leverage fell to 2.15x at June 30, 2026, from 2.27x at March 31, 2026, after a $300.0 million First Lien Facility paydown
BrightSpring Health Services appointed Dr. Nigam H. Shah as a Class III director on June 11, 2026, increasing the Board from seven to eight members. Dr. Shah also joined the Quality and Compliance Committee, and the filing discloses no related-party transactions with him.
Board increased from seven to eight members on June 11, 2026, to fill the new seat with Dr. Shah
Dr. Shah is a Stanford University professor and Chief Data Scientist at Stanford Healthcare
Dr. Shah will receive director compensation under company policy and an indemnification agreement is planned
Press release dated June 12, 2026 furnished as Exhibit 99.1
Selling stockholders, including KKR Phoenix Aggregator L.P. and management, sold 14,999,771 BrightSpring common shares in an underwritten offering priced at $58.75 per share, with closing on June 5, 2026. The company did not receive offering proceeds, except cash from option exercises by management sellers, but it separately bought back 1,026,465 shares from the underwriter, which shareholders should note as a change in the share count and float.
Offering: 14,999,771 shares of common stock sold by selling stockholders at $58.75 per share, under a June 3, 2026 underwriting agreement with Goldman Sachs & Co. LLC
Company repurchase: BrightSpring bought 1,026,465 shares from the underwriter as part of the offering; the underwriter received no fees on these shares
Proceeds: the company received no offering proceeds beyond cash from management stock option exercises
Filing: offering made under a Form S-3ASR shelf registration filed June 10, 2025; closing occurred June 5, 2026
BrightSpring reported first-quarter 2026 net revenue of $3,614 million, up 25.6%, and net income from continuing operations of $74 million, compared with $9 million a year earlier. It increased full-year 2026 revenue guidance to $14,725 million to $15,225 million and Adjusted EBITDA guidance to $795 million to $825 million, which excludes the divested Community Living business.
Q1 2026 net revenue of $3,614 million, up 25.6% from $2,878 million in Q1 2025
Net income from continuing operations of $74 million versus $9 million; Adjusted EBITDA of $190 million, up 44.8%
Full-year 2026 Adjusted EBITDA guidance raised to $795 million to $825 million
Community Living divestiture to Sevita closed March 30, 2026, with a $31.2 million gain on sale, net of tax, in discontinued operations
BrightSpring Health Services completed the sale of its Community Living business to National Mentor Holdings (Sevita) on March 30, 2026, for $835 million in cash, subject to customary adjustments. The filing also says the company expects to repay $425 million of its first lien term loan after closing, and that Community Living president Robert Barnes resigned effective at closing.
Aggregate cash consideration at closing: $835 million, subject to working capital and other customary adjustments
Closing date: March 30, 2026; the company issued a press release on March 31, 2026
Expected repayment of $425 million of the first lien term loan after closing
Robert Barnes resigned as President, ResCare Community Living; accelerated vesting of 15,540 RSUs and 5,640 stock options, with no severance
BrightSpring Health Services agreed on March 2, 2026 to a secondary offering of 20,000,000 common shares at $41.15 per share, all sold by selling stockholders including KKR Phoenix Aggregator L.P. The offering closed March 4, 2026, and the company did not receive offering proceeds, but it repurchased 1,464,807 shares from the underwriter, which the filing says carried no underwriting fees.
Offering: 20,000,000 common shares sold by selling stockholders at $41.15 per share, led by Goldman Sachs & Co. LLC as underwriter
Company received no offering proceeds, apart from cash from management stock option exercises
Company repurchased 1,464,807 shares from the underwriter as part of the offering, with no underwriting fees
Offering was made under an automatic shelf registration filed June 10, 2025; closing occurred March 4, 2026
BrightSpring reported fourth-quarter 2025 revenue of $3,551 million, up 29.3%, and net income from continuing operations of $49.6 million, up from $4.3 million a year earlier. The company also initiated full-year 2026 revenue guidance of $14,450 million to $15,000 million and Adjusted EBITDA guidance of $760 million to $790 million, both excluding the Community Living business.
Q4 2025 Adjusted EBITDA was $184 million, up 40.7% from $130 million; full-year 2025 Adjusted EBITDA was $618 million, up 34.2%.
Full-year 2025 net income from continuing operations was $104.8 million, compared with a net loss of $68.9 million in 2024.
Leverage fell to 2.99x at December 31, 2025, from 4.16x a year earlier.
The Community Living divestiture to Sevita is expected to close by the end of the first quarter of 2026.
BrightSpring Health Services reported third-quarter 2025 revenue of $3,334 million, up 28.2% from a year earlier, and Adjusted EBITDA of $160 million, up 37.2%. The company raised its full-year 2025 revenue guidance and reiterated its Adjusted EBITDA guidance, which matters to shareholders because the headline sales and profit measures both improved.
Q3 2025 revenue was $3,334 million, up 28.2% from $2,601 million; continuing-operations net income was $37.5 million versus a net loss of $25.7 million a year earlier.
Adjusted EBITDA was $160 million, up 37.2% from $117 million.
2025 revenue guidance was raised to $12,500 million to $12,800 million; Adjusted EBITDA guidance of $605 million to $615 million was reiterated.
The planned sale of the Community Living business to Sevita is expected to close in Q1 2026.
BrightSpring Health Services agreed on October 20, 2025 to an underwritten secondary offering of 15,000,000 common shares sold by KKR Phoenix Aggregator L.P. and management stockholders, closing October 22, 2025. The company received no proceeds, but it separately repurchased 1,500,000 shares from the underwriter, BofA Securities, with no underwriting fee.
Selling stockholders sold all 15,000,000 shares of common stock in the offering, led by KKR Phoenix Aggregator L.P. and management sellers.
BrightSpring bought back 1,500,000 shares from BofA Securities as part of the offering; the underwriter received no fee on those shares.
The company received no offering proceeds, apart from cash from management stock option exercises.
The offering was made under an automatic shelf registration filed June 10, 2025; the underwriting agreement is filed as Exhibit 1.1.
BrightSpring Health Services reported preliminary third-quarter 2025 results for continuing operations, with revenue of approximately $3,334 million, up 28.2%, and Adjusted EBITDA of approximately $160 million, up 37.2%. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, which excludes the pending Community Living divestiture to Sevita. The results are preliminary, and full third-quarter results will be announced on October 28, 2025.
Q3 2025 revenue of approximately $3,334 million, up 28.2% from approximately $2,601 million; Adjusted EBITDA of approximately $160 million, up 37.2% from approximately $117 million.
Q3 2025 net income of approximately $37.5 million, compared with a net loss of approximately $25.7 million in Q3 2024.
2025 revenue guidance raised to $12,400 million to $12,700 million; Adjusted EBITDA guidance raised to $605 million to $615 million.
Community Living divestiture to Sevita is expected to close in early Q1 2026; full Q3 results and conference call on October 28, 2025.
BrightSpring Health Services reported second-quarter 2025 results on August 1, 2025, with net revenue up 29.1% and Adjusted EBITDA up 28.8%, both excluding the Community Living business. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, while net income from continuing operations was flat at $8.5 million. The planned sale of Community Living to Sevita is expected to close in the fourth quarter of 2025.
Q2 2025 net revenue was $3,148 million, up 29.1% from $2,438 million a year earlier.
Adjusted EBITDA was $143 million, up 28.8% from $111 million; net income from continuing operations was $8.5 million, flat year over year.
2025 revenue guidance was raised to $12,200 million-$12,600 million, and Adjusted EBITDA guidance to $590 million-$605 million.
The Community Living divestiture to Sevita, announced January 20, 2025, is expected to close in Q4 2025.
BrightSpring said Michael McMaude resigned on June 20, 2025 as President of Hospice Services and as CEO of subsidiary Abode Healthcare, effective immediately, and that he is not leaving over any disagreement with the company. He will continue as a non-employee consultant through the earlier of January 26, 2027 or early termination, under a Resignation Agreement that the filing says includes stock option and equity provisions, and restrictive covenants.
Resigned as President of Hospice Services and CEO of Abode Healthcare, effective June 20, 2025
Consulting period runs until the earlier of January 26, 2027 or early termination
Consulting fee of $2,000 per month, plus $12,000 for the first 45 days, plus pre-approved expenses
Unvested options, RSUs and phantom shares keep vesting during consulting; full filing attached as Exhibit 10.1
BrightSpring filed an 8-K describing an underwritten offering of 14,000,000 common shares at $21.75 per share, sold entirely by selling stockholders led by KKR Phoenix Aggregator L.P. The company did not receive proceeds from the sale, apart from cash from management option exercises, and the offering closed on June 12, 2025. The filing shows a secondary sale of existing shares rather than new capital raised by the company.
Offering: 14,000,000 shares of common stock at a public price of $21.75 per share, before underwriting discounts and commissions
Selling stockholders include KKR Phoenix Aggregator L.P. and management; the underwriters have a 30-day option to buy up to 2,100,000 more shares from KKR
Company received no offering proceeds, other than cash from management stock option exercises
Underwriting agreement dated June 10, 2025; closing occurred June 12, 2025
BrightSpring reported first quarter 2025 results on May 2, 2025, with net revenue of $2,878 million, up 25.9%, and net income from continuing operations of $9.2 million, compared with a loss of $56.0 million a year earlier. The company raised its full-year 2025 revenue guidance to $12,000 million to $12,500 million and Adjusted EBITDA guidance to $570 million to $585 million, and said the planned sale of its Community Living business to Sevita remains on track this year.
Net revenue of $2,878 million, up 25.9% from $2,286 million in Q1 2024
Net income from continuing operations of $9.2 million, versus a net loss from continuing operations of $56.0 million in Q1 2024
Adjusted EBITDA of $131 million, up 28.2% from $102 million
2025 guidance raised: revenue of $12,000 million to $12,500 million; Adjusted EBITDA of $570 million to $585 million
BrightSpring reported fourth-quarter and full-year 2024 results and raised its 2025 revenue and Adjusted EBITDA guidance, excluding the Community Living business it agreed on January 20, 2025 to sell to Sevita for $835 million. Full-year net loss narrowed to $20.5 million from $156.8 million in 2023, while revenue and Adjusted EBITDA both grew.
Q4 2024 net revenue of $3,053 million, up 28.6%; Q4 net income of $15.4 million versus a net loss of $7.2 million in Q4 2023
Full-year 2024 net revenue of $11,266 million, up 27.6%; Adjusted EBITDA of $588 million, up 9.3%
2025 guidance raised: revenue of $11,600 million to $12,100 million and Adjusted EBITDA of $545 million to $560 million, excluding Community Living
Community Living divestiture to Sevita for $835 million, subject to customary closing adjustments
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every BrightSpring Health Services filing is on SEC EDGAR ↗. 8-K briefs of other companies →